MeCP2 is a fundamental protein associated with several neurological disorders, including Rett syndrome. It is considered a multifunctional factor with a prominent role in regulating chromatin structure; however, a full comprehension of the consequences of its deficiency is still lacking. Here, we characterize a novel mouse model of Mecp2 bearing the human mutation Y120D, which is localized in the methyl-binding domain. As most models of Mecp2, the Mecp2Y120D mouse develops a severe Rett-like phenotype. This mutation alters the interaction of the protein with chromatin, but surprisingly, it also impairs its association with corepressors independently on the involved interacting domains. These features, which become overt mainly in the mature brain, cause a more accessible and transcriptionally active chromatin structure; conversely, in the Mecp2-null brain, we find a less accessible and transcriptionally inactive chromatin. By demonstrating that different MECP2 mutations can produce concordant neurological phenotypes but discordant molecular features, we highlight the importance of considering personalized approaches for the treatment of Rett syndrome.

A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome / A. Gandaglia, E. Brivio, S. Carli, M. Palmieri, F. Bedogni, G. Stefanelli, A. Bergo, B. Leva, C. Cattaneo, L. Pizzamiglio, M. Cicerone, V. Bianchi, C. Kilstrup-Nielsen, I. D'Annessa, D. Di Marino, P. D'Adamo, F. Antonucci, A. Frasca, N. Landsberger. - In: MOLECULAR NEUROBIOLOGY. - ISSN 0893-7648. - 56:7(2019 Jul), pp. 4838-4854. [10.1007/s12035-018-1412-2]

A Novel Mecp2Y120D Knock-in Model Displays Similar Behavioral Traits But Distinct Molecular Features Compared to the Mecp2-Null Mouse Implying Precision Medicine for the Treatment of Rett Syndrome

F. Bedogni;L. Pizzamiglio;F. Antonucci;A. Frasca
Penultimo
;
N. Landsberger
Ultimo
2019

Abstract

MeCP2 is a fundamental protein associated with several neurological disorders, including Rett syndrome. It is considered a multifunctional factor with a prominent role in regulating chromatin structure; however, a full comprehension of the consequences of its deficiency is still lacking. Here, we characterize a novel mouse model of Mecp2 bearing the human mutation Y120D, which is localized in the methyl-binding domain. As most models of Mecp2, the Mecp2Y120D mouse develops a severe Rett-like phenotype. This mutation alters the interaction of the protein with chromatin, but surprisingly, it also impairs its association with corepressors independently on the involved interacting domains. These features, which become overt mainly in the mature brain, cause a more accessible and transcriptionally active chromatin structure; conversely, in the Mecp2-null brain, we find a less accessible and transcriptionally inactive chromatin. By demonstrating that different MECP2 mutations can produce concordant neurological phenotypes but discordant molecular features, we highlight the importance of considering personalized approaches for the treatment of Rett syndrome.
Chromatin accessibility; Chromatin binding; MeCP2; mouse models; Rett syndrome<
Settore BIO/14 - Farmacologia
Settore BIO/11 - Biologia Molecolare
lug-2019
6-nov-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Gandaglia et al post-print.pdf

Open Access dal 06/02/2020

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 1.81 MB
Formato Adobe PDF
1.81 MB Adobe PDF Visualizza/Apri
Gandaglia2018_Article_ANovelMecp2Y120DKnock-inModelD.pdf

accesso riservato

Descrizione: Online first
Tipologia: Publisher's version/PDF
Dimensione 7.28 MB
Formato Adobe PDF
7.28 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Gandaglia2019_Article_ANovelMecp2Y120DKnock-inModelD.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 7.27 MB
Formato Adobe PDF
7.27 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/606657
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 15
social impact